IRIS Accounts Production v25.4.0.155 09041365 director 1.9.24 31.8.25 31.8.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh090413652024-08-31090413652025-08-31090413652024-09-012025-08-31090413652023-08-31090413652023-09-012024-08-31090413652024-08-3109041365ns15:EnglandWales2024-09-012025-08-3109041365ns14:PoundSterling2024-09-012025-08-3109041365ns10:Director12024-09-012025-08-3109041365ns10:PrivateLimitedCompanyLtd2024-09-012025-08-3109041365ns10:SmallEntities2024-09-012025-08-3109041365ns10:AuditExempt-NoAccountantsReport2024-09-012025-08-3109041365ns10:SmallCompaniesRegimeForDirectorsReport2024-09-012025-08-3109041365ns10:SmallCompaniesRegimeForAccounts2024-09-012025-08-3109041365ns10:FullAccounts2024-09-012025-08-3109041365ns10:RegisteredOffice2024-09-012025-08-3109041365ns5:CurrentFinancialInstruments2025-08-3109041365ns5:CurrentFinancialInstruments2024-08-3109041365ns5:Non-currentFinancialInstruments2025-08-3109041365ns5:Non-currentFinancialInstruments2024-08-3109041365ns5:ShareCapital2025-08-3109041365ns5:ShareCapital2024-08-3109041365ns5:SharePremium2025-08-3109041365ns5:SharePremium2024-08-3109041365ns5:RetainedEarningsAccumulatedLosses2025-08-3109041365ns5:RetainedEarningsAccumulatedLosses2024-08-3109041365ns5:PlantMachinery2024-08-3109041365ns5:PlantMachinery2024-09-012025-08-3109041365ns5:PlantMachinery2025-08-3109041365ns5:PlantMachinery2024-08-3109041365ns5:WithinOneYearns5:CurrentFinancialInstruments2025-08-3109041365ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-31
REGISTERED NUMBER: 09041365 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 AUGUST 2025

FOR

STAR BLOODSTOCK LIMITED

STAR BLOODSTOCK LIMITED (REGISTERED NUMBER: 09041365)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 August 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


STAR BLOODSTOCK LIMITED

COMPANY INFORMATION
for the year ended 31 August 2025







DIRECTOR: M J Eves





REGISTERED OFFICE: Lakeside House
4 Smith Way
Grove Park
Leicester
Leicestershire
LE19 1SX





REGISTERED NUMBER: 09041365 (England and Wales)





ACCOUNTANTS: Magma Audit LLP (part of the Dains Group)
Lakeside House
4 Smith Way
Grove Park
Leicester
LE19 1SX

STAR BLOODSTOCK LIMITED (REGISTERED NUMBER: 09041365)

BALANCE SHEET
31 August 2025

2025 2024
Notes £    £   
FIXED ASSETS
Tangible assets 4 1,317 939

CURRENT ASSETS
Stocks 208,876 62,314
Debtors 5 71,596 136,901
Cash at bank 19,335 48,157
299,807 247,372
CREDITORS
Amounts falling due within one year 6 (183,031 ) (231,735 )
NET CURRENT ASSETS 116,776 15,637
TOTAL ASSETS LESS CURRENT
LIABILITIES

118,093

16,576

CREDITORS
Amounts falling due after more than one year 7 - (7,206 )
NET ASSETS 118,093 9,370

CAPITAL AND RESERVES
Called up share capital 204,000 204,000
Share premium 76,000 76,000
Retained earnings (161,907 ) (270,630 )
SHAREHOLDERS' FUNDS 118,093 9,370

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

STAR BLOODSTOCK LIMITED (REGISTERED NUMBER: 09041365)

BALANCE SHEET - continued
31 August 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 August 2026 and were signed by:





M J Eves - Director


STAR BLOODSTOCK LIMITED (REGISTERED NUMBER: 09041365)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 August 2025


1. STATUTORY INFORMATION

Star Bloodstock Limited is a limited company, limited by shares, registered in England and Wales. Its registered office address is Lakeside House, 4 Smith Way, Grove Park, Leicester, LE19 1SX and the registered number is 09041365.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The presentational currency of the financial statements is the Pound Sterling (£) and amounts are rounded to the nearest £1.

Turnover
Turnover represents the sale of race ready two year old horses in training in the period.

Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services
Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

- the amount of revenue can be measured reliably;
- it is probable that the Company will receive the consideration due under the contract;
- the stage of completion of the contract at the end of the reporting period can be measured reliably; and
- the costs incurred and the costs to complete the contract can be measured reliably.

Tangible fixed assets
Tangible fixed assets are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using either a straight line or reducing balance method, as indicated below.

Depreciation is provided on the following basis:

Computer Equipment33%Straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Valuation of horses
The carrying value for the horses is the lower of cost and valuation at the period end.

STAR BLOODSTOCK LIMITED (REGISTERED NUMBER: 09041365)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 August 2025


2. ACCOUNTING POLICIES - continued

Financial instruments
(i) Financial assets

Basic financial assets, including trade and other debtors, cash and bank balances are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest rate method.

(ii) Financial liabilities

Basic financial liabilities, including trade and other creditors are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate.

Taxation
The tax expense for the year comprises current and deferred tax.

Tax is recognised in the profit and loss account, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or direct in equity respectively.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
- The recognition of deferred tax assets is limited to the extent that it is probably that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
- Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowance have been met.

Both current and deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Cash and cash equivalents
Cash and cash equivalents are represented by cash in hand, deposits held at call with financial institutions, and other short-term highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

STAR BLOODSTOCK LIMITED (REGISTERED NUMBER: 09041365)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 August 2025


4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 September 2024 2,080
Additions 1,065
At 31 August 2025 3,145
DEPRECIATION
At 1 September 2024 1,141
Charge for year 687
At 31 August 2025 1,828
NET BOOK VALUE
At 31 August 2025 1,317
At 31 August 2024 939

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 1,050 62,274
Other debtors 70,546 74,627
71,596 136,901

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 7,452 10,000
Trade creditors 143,670 190,251
Other creditors 31,909 31,484
183,031 231,735

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Bank loans - 7,206

8. RELATED PARTY DISCLOSURES

A shareholder of this company was also a director of Equity Growth Partners Limited during the period. At the balance sheet date the balance due from Equity Growth Partners Limited to this company was £49,637 (2024: £42,837)